Optimum BMI cut points to screen asian americans for type 2 diabetes
- PMID: 25665815
- PMCID: PMC4407753
- DOI: 10.2337/dc14-2071
Optimum BMI cut points to screen asian americans for type 2 diabetes
Abstract
Objective: Asian Americans manifest type 2 diabetes at low BMI levels but may not undergo diagnostic testing for diabetes if the currently recommended BMI screening cut point of ≥25 kg/m(2) is followed. We aimed to ascertain an appropriate lower BMI cut point among Asian-American adults without a prior diabetes diagnosis.
Research design and methods: We consolidated data from 1,663 participants, ages ≥45 years, without a prior diabetes diagnosis, from population- and community-based studies, including the Mediators of Atherosclerosis in South Asians Living in America study, the North Kohala Study, the Seattle Japanese American Community Diabetes Study, and the University of California San Diego Filipino Health Study. Clinical measures included a 2-h 75-g oral glucose tolerance test, BMI, and glycosylated hemoglobin (HbA1c).
Results: Mean age was 59.7 years, mean BMI was 25.4 kg/m(2), 58% were women, and type 2 diabetes prevalence (American Diabetes Association 2010 criteria) was 16.9%. At BMI ≥25 kg/m(2), sensitivity (63.7%), specificity (52.8%), and Youden index (0.16) values were low; limiting screening to BMI ≥25 kg/m(2) would miss 36% of Asian Americans with type 2 diabetes. For screening purposes, higher sensitivity is desirable to minimize missing cases, especially if the diagnostic test is relatively simple and inexpensive. At BMI ≥23 kg/m(2), sensitivity (84.7%) was high in the total sample and by sex and Asian-American subgroup and would miss only ∼15% of Asian Americans with diabetes.
Conclusions: The BMI cut point for identifying Asian Americans who should be screened for undiagnosed type 2 diabetes should be <25 kg/m(2), and ≥23 kg/m(2) may be the most practical.
© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
Figures
Similar articles
-
Effectiveness of the CANRISK tool in the identification of dysglycemia in a Canadian South Asian Population.Health Promot Chronic Dis Prev Can. 2018 Jul/Aug;38(7-8):287-294. doi: 10.24095/hpcdp.38.7/8.03. Health Promot Chronic Dis Prev Can. 2018. PMID: 30129716 English, French.
-
BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening.Diabetes Care. 2015 Jan;38(1):150-8. doi: 10.2337/dc14-2391. Diabetes Care. 2015. PMID: 25538311 Free PMC article. Review. No abstract available.
-
Using appropriate body mass index cut points for overweight and obesity among Asian Americans.Prev Med. 2014 Aug;65:1-6. doi: 10.1016/j.ypmed.2014.04.010. Epub 2014 Apr 13. Prev Med. 2014. PMID: 24736092 Free PMC article.
-
A systematic review of overweight, obesity, and type 2 diabetes among Asian American subgroups.Curr Diabetes Rev. 2013 Jul;9(4):312-31. doi: 10.2174/15733998113099990061. Curr Diabetes Rev. 2013. PMID: 23590534 Free PMC article. Review.
-
A1C and diabetes diagnosis among Filipino Americans, Japanese Americans, and Native Hawaiians.Diabetes Care. 2010 Dec;33(12):2626-8. doi: 10.2337/dc10-0958. Epub 2010 Sep 10. Diabetes Care. 2010. PMID: 20833866 Free PMC article.
Cited by
-
Association of BMI and incidence of type 2 diabetes in Saudi population.Health Sci Rep. 2024 Mar 25;7(3):e1951. doi: 10.1002/hsr2.1951. eCollection 2024 Mar. Health Sci Rep. 2024. PMID: 38532824 Free PMC article.
-
Diabetes in South Asians: Uncovering Novel Risk Factors With Longitudinal Epidemiologic Data: Kelly West Award Lecture 2023.Diabetes Care. 2024 Jan 1;47(1):7-16. doi: 10.2337/dci23-0068. Diabetes Care. 2024. PMID: 38117990 Review.
-
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024.Diabetes Care. 2024 Jan 1;47(Suppl 1):S145-S157. doi: 10.2337/dc24-S008. Diabetes Care. 2024. PMID: 38078578 Review.
-
Defining and Diagnosing Obesity in India: A Call for Advocacy and Action.J Obes. 2023 Nov 7;2023:4178121. doi: 10.1155/2023/4178121. eCollection 2023. J Obes. 2023. PMID: 38026823 Free PMC article. Review.
-
Clinical performance and health equity implications of the American Diabetes Association's 2023 screening recommendation for prediabetes and diabetes.Front Endocrinol (Lausanne). 2023 Oct 13;14:1279348. doi: 10.3389/fendo.2023.1279348. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37900145 Free PMC article.
References
-
- International Diabetes Federation IDF Diabetes Atlas. 6th ed.Brussels, Belgium, International Diabetes Federation, 2013
-
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–1053 - PubMed
-
- American Diabetes Association . Standards of medical care in diabetes—2014. Diabetes Care 2014;37(Suppl. 1):S14–S80 - PubMed
-
- WHO Expert Consultation . Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157–163 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DK055460/DK/NIDDK NIH HHS/United States
- T32 HL007028/HL/NHLBI NIH HHS/United States
- DK-35876/DK/NIDDK NIH HHS/United States
- DK-02654/DK/NIDDK NIH HHS/United States
- HL-07028/HL/NHLBI NIH HHS/United States
- R01 DK050703/DK/NIDDK NIH HHS/United States
- R01 HL093009/HL/NHLBI NIH HHS/United States
- P30 DK063720/DK/NIDDK NIH HHS/United States
- RR-00037/RR/NCRR NIH HHS/United States
- G12-RR-03061/RR/NCRR NIH HHS/United States
- K24 DK002654/DK/NIDDK NIH HHS/United States
- K24 DK002860/DK/NIDDK NIH HHS/United States
- M01 RR000037/RR/NCRR NIH HHS/United States
- R03-DK-60575/DK/NIDDK NIH HHS/United States
- DK-02860/DK/NIDDK NIH HHS/United States
- K24 HL112827/HL/NHLBI NIH HHS/United States
- R01 DK031801/DK/NIDDK NIH HHS/United States
- DK-48152/DK/NIDDK NIH HHS/United States
- R01 DK031170/DK/NIDDK NIH HHS/United States
- DK-31801/DK/NIDDK NIH HHS/United States
- U01 HL079163/HL/NHLBI NIH HHS/United States
- DK-17047/DK/NIDDK NIH HHS/United States
- U01-HL-079163/HL/NHLBI NIH HHS/United States
- DK-50703/DK/NIDDK NIH HHS/United States
- R01 HL049293/HL/NHLBI NIH HHS/United States
- R03 DK060575/DK/NIDDK NIH HHS/United States
- K24-HL-112827/HL/NHLBI NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- G12 RR003061/RR/NCRR NIH HHS/United States
- HL-29393/HL/NHLBI NIH HHS/United States
- HL-093009/HL/NHLBI NIH HHS/United States
- P30 DK017047/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical